Source study found

Story checked

A study of 27,000 adults links bean products and soy compounds to lower kidney disease odds (opens in a new tab)

news-medical.net · 2026-11-04

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

2 supported
4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

A study of 27,000 adults links bean products and soy compounds to lower kidney disease odds

news-medical.net · 2026-11-04

The story’s checkable claims.

Read the original story

NewsLink checks it

Mixed

Every claim we could check holds up. Two of six claims match the study. This overall rating is based only on the claims we could check. Four claims the study doesn't address.

2 supported
4 not covered

Open claim evidence

The source study

Associations of beans, bean products, and soy isoflavone intake with chronic kidney disease: a cross-sectional study

Nutrition Journal · 2026Open access

Open source record Open in Tessa

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not coveredResearchers examined the diets and kidney health of more than 27,000 Chinese adults and found differences between whole beans, processed soy foods, and associations in women and men.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that the study examined diet and CKD in 27,003 Northeast China Biobank adults, including beans/bean products and soy isoflavones. However, the abstract profile does not verify the story's stated distinctions between whole/plain beans and processed soy foods, nor women-versus-men association differences. The abstract-reported subgroup issue is ethnicity, especially lack of association in the Han subgroup, not sex.

Study evidence

Higher intake of total beans and bean products (residual-adjusted, highest vs lowest quartile) was associated with lower prevalence of CKD.OR 0.67 (95% CI 0.54–0.82) for highest vs lowest quartile; P for trend < 0.001

“From July 2018 to December 2019, we enrolled 27,003 participants aged ≥ 18 years.”

Study evidence

Higher dietary soy isoflavone intake (highest vs lowest quartile of residual-adjusted intake) was associated with lower prevalence of CKD in multivariable models.OR 0.70 (95% CI 0.58–0.86); P for trend < 0.001

“Investigating the association between beans and bean products intake, soy isoflavones, and CKD in the Northeast China Biobank (NEC-Biobank)”

Claim 2 of 6Not coveredEach standard deviation increase in bean product intake was associated with 15% lower odds of CKD, and those with the highest soy isoflavone intake had 30% lower odds than those with the lowest intake.View evidenceHide evidence

As stated15% lower odds; 30% lower odds

Why this verdict

The soy isoflavone magnitude is supported at abstract level: highest versus lowest quartile OR 0.70, corresponding to about 30% lower odds. But the abstract profile does not report a per-standard-deviation estimate of 15% lower odds for bean product intake, and the available abstract-level bean estimate is for highest versus lowest quartile of total beans/bean products, OR 0.67. The full claim therefore cannot be verified at the supplied evidence depth.

Study evidence

“From July 2018 to December 2019, we enrolled 27,003 participants aged ≥ 18 years.”

Study evidence

“Investigating the association between beans and bean products intake, soy isoflavones, and CKD in the Northeast China Biobank (NEC-Biobank)”

Claim 3 of 6Not coveredPlain bean intake showed no significant association with CKD.View evidenceHide evidence

As statedno significant association

Why this verdict

The abstract-level profile reports associations for total beans/bean products, but it does not provide a separate result for plain bean intake or state that plain beans showed no significant association with CKD.

Study evidence

“From July 2018 to December 2019, we enrolled 27,003 participants aged ≥ 18 years.”

Claim 4 of 6Not coveredThe inverse association for soy isoflavones was stronger in women than in men.View evidenceHide evidence

As statedstronger in women than in men

Why this verdict

The abstract-level profile reports subgroup analyses, but the only specific subgroup finding described is that the inverse association was not observed in the Han ethnicity subgroup. It does not report women-versus-men estimates or state that the soy isoflavone association was stronger in women than in men.

Study evidence

Restricted cubic spline (RCS) analyses were used to evaluate potential nonlinear associations between bean/soy isoflavone intake and CKD prevalence, but the abstract does not report the spline results or model specifications.

“Restricted cubic spline (RCS) analyses were performed to evaluate potential nonlinear associations.”

Claim 5 of 6SupportedA recent study published in Nutrition Journal found that higher consumption of soy isoflavones and bean products was associated with lower odds of having chronic kidney disease (CKD).View evidenceHide evidence

As statedlower odds

Why this verdict

The abstract-level profile reports that higher intake of total beans/bean products and higher soy isoflavone intake were inversely associated with prevalent CKD in multivariable models. The story frames this as an association with lower odds, not as causal prevention.

Study evidence

“From July 2018 to December 2019, we enrolled 27,003 participants aged ≥ 18 years.”

Study evidence

“Investigating the association between beans and bean products intake, soy isoflavones, and CKD in the Northeast China Biobank (NEC-Biobank)”

Claim 6 of 6SupportedThe findings may help guide future research, but the study cannot establish that these foods prevent CKD.View evidenceHide evidence

Why this verdict

The profile explicitly states that the cross-sectional observational design cannot establish temporality or causality and that prospective studies are needed. The story's statement that the findings may guide future research but cannot prove prevention is appropriately hedged.

Study evidence

“From July 2018 to December 2019, we enrolled 27,003 participants aged ≥ 18 years.”

Study evidence

“Investigating the association between beans and bean products intake, soy isoflavones, and CKD in the Northeast China Biobank (NEC-Biobank)”

Then look for missing context

Context layer

What the story carried across

Nothing material from the study was dropped.

7 things the story did carry across

Cross-sectional NEC-Biobank analysis of 27,003 adults from Northeast China assessing diet and prevalent CKD.
Dietary intake was assessed using a validated 110-item semi-quantitative FFQ, with energy adjustment using the nutrient residual method.
CKD was defined by reduced eGFR or proteinuria and modeled as prevalent CKD in logistic regression.
Higher total beans/bean products intake was associated with lower CKD prevalence; highest versus lowest quartile OR 0.67.
Higher soy isoflavone intake was associated with lower CKD prevalence; highest versus lowest quartile OR 0.70.
Cross-sectional observational design prevents causal inference and requires confirmation in prospective studies.
FFQ-based intake estimation may introduce dietary measurement error or misclassification.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoEstimate the association between beans/bean products intake and prevalent chronic kidney disease (CKD) in the Northeast China Biobank (NEC-Biobank) adult population.NEC-Biobank cross-sectional dietary analysisExpand

In plain English

Cross-sectional analysis of 27,003 adults in the Northeast China Biobank (July 2018–Dec 2019) found that higher residual-adjusted intake of total beans and bean products, and higher soy isoflavone intake, were each inversely associated with prevalent chronic kidney disease (CKD). After multivariable adjustment, participants in the highest quartile of total beans/bean products had lower odds of CKD compared with the lowest quartile (OR 0.67, 95% CI 0.54–0.82), and the highest quartile of soy isoflavones had OR 0.70 (95% CI 0.58–0.86).

Key findings

Higher intake of total beans and bean products (residual-adjusted, highest vs lowest quartile) was associated with lower prevalence of CKD.OR 0.67 (95% CI 0.54–0.82) for highest vs lowest quartile; P for trend < 0.001
Higher soy isoflavone intake (highest vs lowest quartile) was associated with lower prevalence of CKD.OR 0.70 (95% CI 0.58–0.86) for highest vs lowest quartile; P for trend < 0.001

“From July 2018 to December 2019, we enrolled 27,003 participants aged ≥ 18 years.”

What this piece can’t prove

Cross-sectional design: associations cannot establish temporality or causality; authors state findings require confirmation in prospective studies.

2human in vivoEstimate the association between dietary soy isoflavone intake and prevalent CKD in the same NEC-Biobank population.Cross-sectional analysis (NEC-Biobank)Expand

In plain English

In a cross-sectional analysis of 27,003 adults from the Northeast China Biobank, higher dietary soy isoflavone intake (FFQ-derived, energy-adjusted by the nutrient residual method and analyzed in quartiles) was associated with lower prevalence of chronic kidney disease (CKD) after multivariable adjustment: highest versus lowest quartile OR 0.70 (95% CI 0.58–0.86), P for trend < 0.001. CKD was defined by reduced estimated glomerular filtration rate or presence of proteinuria. The association persisted in subgroup analyses except in the Han ethnicity subgroup. Due to the study's cross-sectional design, causality cannot be inferred.

Key findings

Higher dietary soy isoflavone intake (highest vs lowest quartile of residual-adjusted intake) was associated with lower prevalence of CKD in multivariable models.OR 0.70 (95% CI 0.58–0.86); P for trend < 0.001

“Investigating the association between beans and bean products intake, soy isoflavones, and CKD in the Northeast China Biobank (NEC-Biobank)”

What this piece can’t prove

Cross-sectional study design limits causal inference (explicitly stated in abstract).
Dietary exposure estimated from FFQ; potential for measurement error and misclassification of soy isoflavone intake.

1 further detail could not be confirmed from the summary.

3human in vivoAssess potential nonlinearity and effect modification (subgroup differences, e.g., ethnicity) in the diet–CKD associations.Cross-sectional covariate-adjusted logistic regression with nutrient-residual-adjusted exposures, restricted cubic spline modeling, and stratified subgroup analysesExpand

In plain English

The study applied restricted cubic spline (RCS) modeling within covariate-adjusted logistic regression and conducted subgroup (stratified) analyses to assess potential nonlinear exposure–CKD relationships and effect modification (including by ethnicity). The abstract reports that RCS analyses were performed but does not report spline results or specifications; subgroup analyses reportedly showed the inverse association persisted across subgroups except in the Han ethnicity group, with no subgroup-specific estimates or interaction test details provided.

Key findings

Restricted cubic spline (RCS) analyses were used to evaluate potential nonlinear associations between bean/soy isoflavone intake and CKD prevalence, but the abstract does not report the spline results or model specifications.
Subgroup analyses reported that the inverse association between beans/bean products or soy isoflavone intake and CKD prevalence was observed across subgroups except in the Han ethnicity group.

“Restricted cubic spline (RCS) analyses were performed to evaluate potential nonlinear associations.”

What this piece can’t prove

Cross-sectional design prevents causal inference and temporality assessment.
Abstract lacks RCS model details (knot placement/number) and does not report spline results, limiting interpretation of nonlinearity assessment.

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer